Clinical Trials at Pars Medicine
Clinical trials are essential to advancing medical care, developing new treatments, and improving patient outcomes. At Pars Medicine, we conduct cutting-edge clinical research across diverse therapeutic areas, offering patients access to innovative investigational therapies while contributing to medical knowledge that benefits people worldwide.
Our Clinical Research Mission
The Clinical Trials Program at Pars Medicine is dedicated to conducting rigorous, ethical research that translates scientific discoveries into improved patient care. We are committed to:
- Providing patients with access to promising new treatments through clinical trials
- Conducting high-quality research that meets the highest scientific and ethical standards
- Advancing medical knowledge across diverse disease areas and patient populations
- Ensuring patient safety, informed consent, and protection of participant rights
- Promoting diversity, equity, and inclusion in clinical research
Current Clinical Trials
Pars Medicine currently conducts over 200 active clinical trials spanning all phases of investigation (Phase I through Phase IV) across multiple therapeutic areas:
Oncology Trials
Investigating novel cancer therapies including immunotherapies, targeted therapies, combination treatments, and precision medicine approaches for solid tumors and hematologic malignancies. Active trials include studies of breast cancer, lung cancer, colorectal cancer, lymphoma, leukemia, and pediatric cancers.
Cardiovascular Trials
Testing new treatments for heart failure, coronary artery disease, arrhythmias, hypertension, and stroke prevention. Studies include novel medications, medical devices, interventional procedures, and lifestyle interventions.
Neurology and Psychiatry Trials
Evaluating therapies for Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, depression, anxiety disorders, and schizophrenia. Trials encompass pharmacologic agents, neuromodulation devices, and behavioral interventions.
Infectious Disease Trials
Studying new antimicrobial agents, antiviral therapies, vaccines, and treatment strategies for bacterial, viral, and fungal infections including emerging infectious diseases and antimicrobial-resistant organisms.
Metabolic and Endocrine Trials
Investigating treatments for diabetes, obesity, thyroid disorders, osteoporosis, and metabolic syndrome. Studies include novel medications, continuous glucose monitoring systems, and comprehensive lifestyle interventions.
Immunology and Rheumatology Trials
Testing therapies for rheumatoid arthritis, lupus, inflammatory bowel disease, psoriasis, and other autoimmune conditions. Trials feature biologics, small molecule inhibitors, and immunomodulatory agents.
Respiratory Disease Trials
Evaluating treatments for asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and cystic fibrosis including novel inhalers, biologics, and combination therapies.
Other Therapeutic Areas
Additional trials address nephrology, hepatology, dermatology, ophthalmology, women's health, pediatrics, rare diseases, and preventive medicine.
How to Participate in Clinical Trials
Participating in a clinical trial may provide access to promising new treatments while contributing to medical research. Here's how to get started:
Step 1: Search for Trials
Use our Clinical Trials Search Tool to find studies matching your condition, or search ClinicalTrials.gov for Pars Medicine studies. You may also ask your physician about relevant trials.
Step 2: Contact the Research Team
Each trial listing includes contact information for the study coordinator. Contact them to learn more about the study, ask questions, and express interest in participation.
Step 3: Screening and Eligibility
The research team will review your medical history to determine if you meet eligibility criteria. Each trial has specific inclusion and exclusion criteria based on age, diagnosis, disease stage, prior treatments, and other medical factors.
Step 4: Informed Consent
If eligible, you'll meet with the research team to discuss the study in detail. You'll receive an informed consent document explaining the study purpose, procedures, potential risks and benefits, alternatives, and your rights. Take time to read carefully, ask questions, and discuss with family before deciding.
Step 5: Enrollment and Participation
If you choose to enroll, you'll undergo baseline evaluations and begin the study. Throughout participation, you'll have regular visits for monitoring, testing, and assessment. You may withdraw from a study at any time for any reason.
Patient Protections and Safety
Your safety and wellbeing are our highest priorities. All clinical trials at Pars Medicine include comprehensive protections:
Institutional Review Board (IRB) Oversight
Every clinical trial is reviewed and approved by our independent IRB, which includes physicians, scientists, ethicists, and community members. The IRB ensures studies are ethical, scientifically sound, and include appropriate safeguards.
Informed Consent
All participants receive detailed information about the study and provide voluntary, written informed consent before enrollment. Consent is an ongoing process, and you may ask questions or withdraw at any time.
Safety Monitoring
Research teams closely monitor participants for adverse events. Independent Data Safety Monitoring Boards (DSMBs) review safety data for many trials, with authority to modify or stop studies if safety concerns arise.
Participant Rights
You have the right to:
- Understand the study purpose, procedures, risks, and benefits
- Ask questions at any time
- Decline participation without affecting your regular medical care
- Withdraw from the study at any time without penalty
- Privacy and confidentiality of your medical information
- Receive information about study results
Benefits and Risks of Participation
Potential Benefits
- Access to new treatments not yet widely available
- Close monitoring and care from expert research teams
- Contribution to medical knowledge that may help future patients
- No cost for study-related care (investigational treatment, tests, procedures)
- Possible compensation for time and travel expenses
Potential Risks
- Unknown side effects from investigational treatments
- Possibility that the new treatment may not be effective
- Additional time commitment for study visits and procedures
- Potential need for additional tests, blood draws, or imaging
- Randomization (in some studies) to standard treatment rather than experimental therapy
Diversity in Clinical Research
We are committed to ensuring clinical trials reflect the diversity of patients who will ultimately use new treatments. We actively recruit participants from diverse racial, ethnic, age, gender, and socioeconomic backgrounds. We provide language assistance, transportation support, and flexible scheduling to reduce barriers to participation.
Clinical Trials Office Resources
Our Clinical Trials Office provides comprehensive support including:
- Patient navigation and trial matching assistance
- Educational materials about clinical research
- Financial counseling regarding insurance coverage
- Transportation and lodging assistance for out-of-town participants
- Translation and interpretation services
- Patient advocate support
For Physicians and Referring Providers
Healthcare providers may refer patients to clinical trials by contacting our Physician Referral Line at 555-0250 or emailing
Learn more or find a trial: Visit our Clinical Trials Search, call 555-0225, or email